Acute Abdominal Pain - Revision history

Treloars at 00:41, 24 April 2020

2020-04-24T00:41:57Z

Treloars at 01:59, 31 January 2018

2018-01-31T01:59:48Z

← Older revision		Revision as of 01:59, 31 January 2018
Line 28:		Line 28:
	* Administer nothing by mouth.		* Administer nothing by mouth.

	[[Category:Medical]]		[[Category:Medical\|0501]]

Treloars: /* 5.01 ACUTE ABDOMINAL PAIN */

2016-04-27T01:24:08Z

5.01 ACUTE ABDOMINAL PAIN

← Older revision		Revision as of 01:24, 27 April 2016
Line 14:		Line 14:
	** [[Antiemetics\|PHENERGAN (PROMETHAZINE)]]:		** [[Antiemetics\|PHENERGAN (PROMETHAZINE)]]:
	*** Adult (>13 y/o): 12.5 MG DILUTED and slow IVP or IM.		*** Adult (>13 y/o): 12.5 MG DILUTED and slow IVP or IM.
	*** Pediatric: ~~refer to Handtevy System~~		*** Pediatric: 0.25 - 1 mg/kg DILUTED and slow IVP or IM.
	{\| class="wikitable"		{\| class="wikitable"
	\|-		\|-

Treloars at 01:02, 27 April 2016

2016-04-27T01:02:28Z

← Older revision		Revision as of 01:02, 27 April 2016
Line 14:		Line 14:
	** [[Antiemetics\|PHENERGAN (PROMETHAZINE)]]:		** [[Antiemetics\|PHENERGAN (PROMETHAZINE)]]:
	*** Adult (>13 y/o): 12.5 MG DILUTED and slow IVP or IM.		*** Adult (>13 y/o): 12.5 MG DILUTED and slow IVP or IM.
	*** Pediatric: 0.~~25 – 1 mg/Kg DILUTED and slow IVP or IM~~.		*** Pediatric: refer to Handtevy System
			{\| class="wikitable"
			\|-
			! The administration of [[Antiemetics\|PHENERGAN (PROMETHAZINE)]] in pediatric patients should only be considered if there is persistant vomiting and [[Antiemetics\|ZOFRAN (ONDANSETRON HYDROCHLORIDE)]] is not effective.
			\|}
			{\| class="wikitable"
			\|-
			! '''BLACK BOX WARNING'''
			The IV (perenteral) administration of [[Antiemetics\|PHENERGAN (PROMETHAZINE)]] has a '''RELATIVE CONTRAINDICATION''' in children under 2 years of age. The provider must weigh the risk vs. benefit of [[Antiemetics\|PHENERGAN (PROMETHAZINE)]] administration based on the patient's condition.
			\|}
	* If suspected Kidney Stones, refer to [[Suspected Kidney Stone\|SUSPECTED KIDNEY STONE]] parameter (5.18)		* If suspected Kidney Stones, refer to [[Suspected Kidney Stone\|SUSPECTED KIDNEY STONE]] parameter (5.18)
	* Refer to [[Analgesia and Sedation\|ANALGESIA/SEDATION PRACTICE PARAMETERS]] (2.04)		* Refer to [[Analgesia and Sedation\|ANALGESIA/SEDATION PRACTICE PARAMETERS]] (2.04)

Treloars: /* 5.01 ACUTE ABDOMINAL PAIN */

2016-04-25T18:36:40Z

5.01 ACUTE ABDOMINAL PAIN

← Older revision		Revision as of 18:36, 25 April 2016
Line 8:		Line 8:
	* For patients with severe vomiting, obtain detailed history, and then administer an appropriate antiemetic.		* For patients with severe vomiting, obtain detailed history, and then administer an appropriate antiemetic.
	** [[Antiemetics\|ZOFRAN (ONDANSETRON HYDROCHLORIDE)]]:		** [[Antiemetics\|ZOFRAN (ONDANSETRON HYDROCHLORIDE)]]:
	*** Adult ~~(>12 y/o or 40 kg)~~: 4mg slow IVP or 1 ODT tab.		*** Adult: 4mg slow IVP or 1 ODT tab.
	****When administering IV, consider diluting in 10-20cc to aid in administering slowly or 4mg/2ml deep IM in a large muscle.		****When administering IV, consider diluting in 10-20cc to aid in administering slowly or 4mg/2ml deep IM in a large muscle.
	*** Pediatric ~~(<40 kg)~~: ~~0.1mg/kg slow IVP (max of 4mg)~~		*** Pediatric: Refer to Handtevy System
	****For PO administration		***'''NOTE''': Use PO administration route for conscious patients '''ONLY'''.
	*****Pediatric 20-40 kg - Administer 1/2 ODT tab
	*****Children >40 kg - Use adult dose
	****'''NOTE''': Use PO administration route for conscious patients '''ONLY'''.
	** [[Antiemetics\|PHENERGAN (PROMETHAZINE)]]:		** [[Antiemetics\|PHENERGAN (PROMETHAZINE)]]:
	*** Adult (>12 y/o ~~or 40 kg~~): 12.5 MG DILUTED and slow IVP or IM.		*** Adult (>13 y/o): 12.5 MG DILUTED and slow IVP or IM.
	*** Pediatric ~~(<40 Kg)~~: 0.25 – 1 mg/Kg DILUTED and slow IVP or IM.		*** Pediatric: 0.25 – 1 mg/Kg DILUTED and slow IVP or IM.
	* If suspected Kidney Stones, refer to [[Suspected Kidney Stone\|SUSPECTED KIDNEY STONE]] parameter (5.18)		* If suspected Kidney Stones, refer to [[Suspected Kidney Stone\|SUSPECTED KIDNEY STONE]] parameter (5.18)
	* Refer to [[Analgesia and Sedation\|ANALGESIA/SEDATION PRACTICE PARAMETERS]] (2.04)		* Refer to [[Analgesia and Sedation\|ANALGESIA/SEDATION PRACTICE PARAMETERS]] (2.04)

Treloars: /* Section 5 - MEDICAL */

2014-01-13T16:50:17Z

Section 5 - MEDICAL

← Older revision		Revision as of 16:50, 13 January 2014
Line 8:		Line 8:
	* For patients with severe vomiting, obtain detailed history, and then administer an appropriate antiemetic.		* For patients with severe vomiting, obtain detailed history, and then administer an appropriate antiemetic.
	** [[Antiemetics\|ZOFRAN (ONDANSETRON HYDROCHLORIDE)]]:		** [[Antiemetics\|ZOFRAN (ONDANSETRON HYDROCHLORIDE)]]:
	*** Adult (>12 y/o or 40 kg): 4mg slow IVP. ~~(Consider~~ diluting in 10-20cc to aid in administering slowly) or 4mg/2ml deep IM in a large muscle.		*** Adult (>12 y/o or 40 kg): 4mg slow IVP or 1 ODT tab.
			****When administering IV, consider diluting in 10-20cc to aid in administering slowly or 4mg/2ml deep IM in a large muscle.
	*** Pediatric (<40 kg): 0.1mg/kg slow IVP (max of 4mg)		*** Pediatric (<40 kg): 0.1mg/kg slow IVP (max of 4mg)
			****For PO administration
			*****Pediatric 20-40 kg - Administer 1/2 ODT tab
			*****Children >40 kg - Use adult dose
			****'''NOTE''': Use PO administration route for conscious patients '''ONLY'''.
	** [[Antiemetics\|PHENERGAN (PROMETHAZINE)]]:		** [[Antiemetics\|PHENERGAN (PROMETHAZINE)]]:
	*** Adult (>12 y/o or 40 kg): 12.5 MG DILUTED and slow IVP or IM.		*** Adult (>12 y/o or 40 kg): 12.5 MG DILUTED and slow IVP or IM.

Treloars: /* Section 5 - MEDICAL */

2012-04-02T00:56:57Z

Section 5 - MEDICAL

← Older revision		Revision as of 00:56, 2 April 2012
Line 16:		Line 16:
	* Refer to [[Analgesia and Sedation\|ANALGESIA/SEDATION PRACTICE PARAMETERS]] (2.04)		* Refer to [[Analgesia and Sedation\|ANALGESIA/SEDATION PRACTICE PARAMETERS]] (2.04)
	* Administer nothing by mouth.		* Administer nothing by mouth.

			[[Category:Medical]]

Treloars: /* 5.01 ACUTE ABDOMINAL PAIN ver 2 */

2012-02-09T21:04:29Z

5.01 ACUTE ABDOMINAL PAIN ver 2

← Older revision		Revision as of 21:04, 9 February 2012
Line 1:		Line 1:
	== Section 5 - MEDICAL ==		== Section 5 - MEDICAL ==
	=== 5.01 ACUTE ABDOMINAL PAIN ~~ver 2~~ ===		=== 5.01 ACUTE ABDOMINAL PAIN ===

	'''''CONSIDER CARDIAC ETIOLOGY.'''''		'''''CONSIDER CARDIAC ETIOLOGY.'''''

Treloars: /* 5.01 ACUTE ABDOMINAL PAIN */

2012-02-09T21:03:28Z

5.01 ACUTE ABDOMINAL PAIN

← Older revision		Revision as of 21:03, 9 February 2012
Line 1:		Line 1:
	== Section 5 - MEDICAL ==		== Section 5 - MEDICAL ==
	=== 5.01 ACUTE ABDOMINAL PAIN ===		=== 5.01 ACUTE ABDOMINAL PAIN ver 2 ===

	'''''CONSIDER CARDIAC ETIOLOGY.'''''		'''''CONSIDER CARDIAC ETIOLOGY.'''''

Treloars: Created page with "== Section 5 - MEDICAL == === 5.01 ACUTE ABDOMINAL PAIN === '''''CONSIDER CARDIAC ETIOLOGY.''''' INITIAL MEDICAL CARE (2.01) - Provid..."

2012-02-01T21:27:41Z

Created page with "== Section 5 - MEDICAL == === 5.01 ACUTE ABDOMINAL PAIN === '''''CONSIDER CARDIAC ETIOLOGY.''''' INITIAL MEDICAL CARE (2.01) - Provid..."

New page

== Section 5 - MEDICAL ==
=== 5.01 ACUTE ABDOMINAL PAIN ===

'''''CONSIDER CARDIAC ETIOLOGY.'''''

[[Initial Medical Assessment and Care|INITIAL MEDICAL CARE]] (2.01) - Provide OXYGEN or assist ventilations as appropriate for patient condition. Use vomiting precautions.
* If hypotension / shock is present, refer to [[Shock|SHOCK PRACTICE PARAMETER]] (5.13).
* For patients with severe vomiting, obtain detailed history, and then administer an appropriate antiemetic.
** [[Antiemetics|ZOFRAN (ONDANSETRON HYDROCHLORIDE)]]:
*** Adult (>12 y/o or 40 kg): 4mg slow IVP. (Consider diluting in 10-20cc to aid in administering slowly) or 4mg/2ml deep IM in a large muscle.
*** Pediatric (<40 kg): 0.1mg/kg slow IVP (max of 4mg)
** [[Antiemetics|PHENERGAN (PROMETHAZINE)]]:
*** Adult (>12 y/o or 40 kg): 12.5 MG DILUTED and slow IVP or IM.
*** Pediatric (<40 Kg): 0.25 – 1 mg/Kg DILUTED and slow IVP or IM.
* If suspected Kidney Stones, refer to [[Suspected Kidney Stone|SUSPECTED KIDNEY STONE]] parameter (5.18)
* Refer to [[Analgesia and Sedation|ANALGESIA/SEDATION PRACTICE PARAMETERS]] (2.04)
* Administer nothing by mouth.

← Older revision		Revision as of 00:41, 24 April 2020
Line 7:		Line 7:
	* If hypotension / shock is present, refer to [[Shock\|SHOCK PRACTICE PARAMETER]] (5.13).		* If hypotension / shock is present, refer to [[Shock\|SHOCK PRACTICE PARAMETER]] (5.13).
	* For patients with severe vomiting, obtain detailed history, and then administer an appropriate antiemetic.		* For patients with severe vomiting, obtain detailed history, and then administer an appropriate antiemetic.
	** [[~~Antiemetics~~\|ZOFRAN (ONDANSETRON HYDROCHLORIDE)]]:		** [[Zofran\|ZOFRAN (ONDANSETRON HYDROCHLORIDE)]]:
	*** Adult: 4mg slow IVP or 1 ODT tab.		*** Adult: 4mg slow IVP or 1 ODT tab.
	****When administering IV, consider diluting in 10-20cc to aid in administering slowly or 4mg/2ml deep IM in a large muscle.		****When administering IV, consider diluting in 10-20cc to aid in administering slowly or 4mg/2ml deep IM in a large muscle.
	*** Pediatric: Refer to Handtevy System		*** Pediatric: Refer to Handtevy System
	***'''NOTE''': Use PO administration route for conscious patients '''ONLY'''.		***'''NOTE''': Use PO administration route for conscious patients '''ONLY'''.
	** [[~~Antiemetics~~\|PHENERGAN (PROMETHAZINE)]]:		** [[Promethazine\|PHENERGAN (PROMETHAZINE)]]:
	*** Adult (>13 y/o): 12.5 MG DILUTED and slow IVP or IM.		*** Adult (>13 y/o): 12.5 MG DILUTED and slow IVP or IM.
	*** Pediatric: 0.25 - 1 mg/kg DILUTED and slow IVP or IM.		*** Pediatric: 0.25 - 1 mg/kg DILUTED and slow IVP or IM.
	{\| class="wikitable"		{\| class="wikitable"
	\|-		\|-
	! The administration of [[~~Antiemetics~~\|PHENERGAN (PROMETHAZINE)]] in pediatric patients should only be considered if there is persistant vomiting and [[~~Antiemetics~~\|ZOFRAN (ONDANSETRON HYDROCHLORIDE)]] is not effective.		! The administration of [[Promethazine\|PHENERGAN (PROMETHAZINE)]] in pediatric patients should only be considered if there is persistant vomiting and [[Zofran\|ZOFRAN (ONDANSETRON HYDROCHLORIDE)]] is not effective.
	\|}		\|}
	{\| class="wikitable"		{\| class="wikitable"
	\|-		\|-
	! '''BLACK BOX WARNING'''		! '''BLACK BOX WARNING'''
	The IV (perenteral) administration of [[~~Antiemetics~~\|PHENERGAN (PROMETHAZINE)]] has a '''RELATIVE CONTRAINDICATION''' in children under 2 years of age. The provider must weigh the risk vs. benefit of [[~~Antiemetics~~\|PHENERGAN (PROMETHAZINE)]] administration based on the patient's condition.		The IV (perenteral) administration of [[Promethazine\|PHENERGAN (PROMETHAZINE)]] has a '''RELATIVE CONTRAINDICATION''' in children under 2 years of age. The provider must weigh the risk vs. benefit of [[Promethazine\|PHENERGAN (PROMETHAZINE)]] administration based on the patient's condition.
	\|}		\|}
	* If suspected Kidney Stones, refer to [[Suspected Kidney Stone\|SUSPECTED KIDNEY STONE]] parameter (5.18)		* If suspected Kidney Stones, refer to [[Suspected Kidney Stone\|SUSPECTED KIDNEY STONE]] parameter (5.18)